Adeno-associated virus vector-based gene therapies for pediatric diseases
Gene therapy using adeno-associated virus (AAV) is a rapidly developing technology with widespread treatment potential. AAV2 vectors injected directly into the brain by stereotaxic brain surgery have shown good results in treating aromatic l-amino acid decarboxylase deficiency. Moreover, gene therap...
Saved in:
Main Authors: | Kazuhiro Muramatsu (Author), Shin-ichi Muramatsu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
by: Prabhakar Bastola, et al.
Published: (2020) -
Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors
by: Ruth Rieser, et al.
Published: (2021) -
Adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice
by: Estera Rintz, et al.
Published: (2024) -
Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5
by: Daniel J. Schuster, et al.
Published: (2014) -
Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
by: Liam Cole, et al.
Published: (2021)